By Staff
Tuesday, May 17, 2022 12:24 AM
GENEVA—On Monday,
Alcon marked the company’s 75th anniversary with its “Brilliant History, Brilliant Future” celebration. On May 16, 1947, Alcon Laboratories Inc. was incorporated and began manufacturing specialty pharmaceutical products in Fort Worth, Texas, the company noted in its announcement.
By Staff
Friday, May 13, 2022 12:24 AM
VANCOUVER, Canada—
Kits Eyecare Ltd. (TSX: KITS / OTCQX: KTYCF), a direct-to-consumer glasses manufacturer and digital eyecare provider, reported this week that its revenue in the first quarter dipped roughly 2 percent to $20.1 million.
By Staff
Friday, May 13, 2022 12:21 AM
JACKSONVILLE, Fla.—Bringing a long-running price-fixing case closer to a conclusion, a federal judge in Florida this week gave preliminary approval to proposals from
Alcon Vision LLC and
Johnson & Johnson Vision Care that would settle their roles in the matter, according to a May 9 court filing.
By Staff
Thursday, May 12, 2022 12:24 AM
GENEVA—Calling its performance “a strong start to the year,”
Alcon (SIX/NYSE:ALC) reported that worldwide sales increased 14 percent on a reported basis to $2.2 billion in its first quarter ended March 31.
By Staff
Wednesday, May 11, 2022 12:21 AM
LAVAL, Quebec—
Bausch Health Companies Inc. (NYSE/TSX: BHC) yesterday reported $1.918 billion in total revenue for the first quarter of 2022, as compared to $2.027 billion in the first quarter of 2021, a decrease of $109 million, or 5 percent.
By Staff
Tuesday, May 10, 2022 12:21 AM
SAN RAMON, Calif.—
CooperVision, a global leader in myopia management, has kicked off its 2022 Myopia Management Workshop series. The immersive full-day events are designed to accelerate practices’ clinical and business success in the fast-growing sector.
By Staff
Monday, May 9, 2022 12:21 AM
VAUGHAN, Ontario—At the end of a topsy-turvy week for the stock market,
Bausch + Lomb Corp. (NYSE/TSX: BLCO) on Friday launched as an independent, publicly traded company when it began trading under the “BLCO” symbol on the New York Stock Exchange and Toronto Stock Exchange.
By Staff
Friday, May 6, 2022 12:15 AM
SAN RAMON, Calif.—To promote continuous advancement in contact lens research and development,
CooperVision is now accepting submissions for its 2022 Science and Technology Awards program.
By Staff
Thursday, May 5, 2022 12:15 AM
JACKSONVILLE, Fla.—
Johnson & Johnson Vision, a leader in eye health and part of the Johnson & Johnson MedTech Companies, was recognized as the winner of
Fast Company’s 2022 World Changing Ideas Awards in the Wellness category for Acuvue Theravision with Ketotifen (etafilcon A drug-eluting contact lens with ketotifen). Each lens contains 19 mcg ketotifen.
Fast Company also selected Acuvue Theravision with Ketotifen for an honorable mention in both the Health and Enduring Impact: 15+ Years in Business categories, according to the company’s announcement.
By Staff
Wednesday, May 4, 2022 12:33 AM
JACKSONVILLE, Fla. and SANTA ANA, Calif.—
Johnson & Johnson Vision, a global eye health company and part of
Johnson & Johnson MedTech, has named Peter Menziuso as company group chairman, according to an announcement Tuesday. Menziuso now leads the full Johnson & Johnson Vision portfolio, which offers solutions designed to provide healthy sight for life. This includes world-leading brands such as Acuvue contact lenses, Tecnis family of intraocular lenses and TearScience LipiFlow, among other brands and products.
By Staff
Friday, April 29, 2022 12:18 AM
ALBANY, N.Y.—
CooperVision will expand operations at two separate locations in New York state’s Monroe County, Governor Kathy Hochul announced earlier this week. The moves will create up to 173 new jobs, the governor noted. CooperVision said it will invest more than $38 million to significantly renovate its current facility and expand, by 150,000 square feet, its packaging and distribution facility in West Henrietta, N.Y. The expansion comes amid an increase in global demand for its contact lenses and a growing product portfolio, the company said.
By Staff
Thursday, April 28, 2022 11:40 AM
LAVAL, Quebec and VAUGHAN, Ontario—
Bausch + Lomb Corp., a wholly owned subsidiary of
Bausch Health Companies Inc. (NYSE/TSX: BHC) said on Thursday that it is launching an initial public offering (IPO), and intends to list its shares on both the New York Stock Exchange and Toronto Exchange. The company also noted that it will commence a roadshow with prospective investors for the IPO, which was first announced by the parent company in August 2020, as
VMAIL reported.
By Staff
Wednesday, April 27, 2022 12:15 AM
WATERLOO, Ontario—The
Centre for Ocular Research & Education has appointed Rosa Yang, OD, FAAO, as a clinical research associate, a move that supports the growing use of specialty contact lenses worldwide, according to a recent announcement. Dr. Yang also serves as a clinical instructor at the University of Waterloo School of Optometry & Vision Science and is a practicing optometrist in the Greater Toronto Area. CORE’s specialty contact lens-related work spans a range of program areas, including design optimization for orthokeratology, scleral lens physiological performance, and the impact of scleral lenses on ocular surface disease and dry eye management.
By Staff
Tuesday, April 26, 2022 12:27 AM
JACKSONVILLE, Fla.—
Johnson & Johnson Vision, which works to help people around the world see better, connect better and live better, said it understands the value in extending this commitment to ensure it supports the health of the planet as well. “After all, it takes a healthy planet to have healthy people and communities,” the company noted in a recent LinkedIn post coinciding with World Earth Day (April 22). In addition, J&J Vision said late last week that it has made two important changes to the way some products are made and distributed to benefit the planet. The changes and products are: